In line with this, the PDE-4 inhibitor apremilast was applied effectively in patients suffering from the desmosomal autoimmune skin disease pemphigus vulgaris (Meier, Holstein et al. [32], Delvaux, Bohelay et al. [15]). The gene discussed is PDE4A; the disease is pemphigus vulgaris.